Endocrine tumors of the female reproductive tract

Mol Cell Endocrinol. 2024 Mar 1:582:112123. doi: 10.1016/j.mce.2023.112123. Epub 2023 Dec 20.

Abstract

Endocrine cells responsible for hormone secretion are found in virtually every organ system. The diverse neoplasms arising from endocrine cells in the female reproductive tract are not well recognized as a distinct component of endocrine oncology. Here, we integrate cellular origins with native anatomical residence to help classify neoplasms of this system. The neoplasms include steroidogenic tumors that arise usually in ovarian stroma, neuroendocrine neoplasms that can arise from normal neuroendocrine cells throughout the female reproductive tract or in ovarian germ cell tumors, and thyroid follicular cell proliferations that are exclusively a component of an ovarian teratoma and may be malignant. The neuroendocrine neoplasms run the full spectrum from indolent neuroendocrine tumors to aggressive poorly differentiated neuroendocrine carcinomas. While many of these lesions are identified as incidental findings in surgically resected tissues, others present with inappropriate hormone excess. An important consideration is the distinction of primary disease from metastatic malignancy. Genetic disorders including those caused by germline mutations of the FOXL2, GNAS, DICER1, STK11 and MEN1 genes can present with primary endocrine neoplasms of the female reproductive tract.

MeSH terms

  • DEAD-box RNA Helicases / genetics
  • Female
  • Germ-Line Mutation
  • Hormones
  • Humans
  • Neuroendocrine Tumors* / genetics
  • Neuroendocrine Tumors* / pathology
  • Ovarian Neoplasms* / genetics
  • Ovarian Neoplasms* / pathology
  • Ribonuclease III / genetics
  • Teratoma* / pathology

Substances

  • Hormones
  • DICER1 protein, human
  • Ribonuclease III
  • DEAD-box RNA Helicases